Media Coverage

4G Clinical's Kathleen Greenough published an article for International Clinical Trials, about adaptive trial design as the future of oncology studies.

Neta Bendelac, Senior Director, Strategy, speaks with Drug Discovery Trends about COVID testing, and how clinical trials need to stay ahead of mutations.

Elizabeth Rickenbacher, PhD, Director of Strategy for 4G Clinical discusses changes in the IRT and RTSM solutions with Applied Clinical Trials.

Dave Kelleher, CEO of 4G Clinical, speaks with ACRP about how patient choice will determine the future adoption of decentralized clinical trials.

David Kelleher speaks about how $230M from Goldman Sachs will help expand their RTSM further into Asia Pacific and more clinical trials.

In this podcast, SCRS talks with 4G Clinical's Senior Director of Strategy, Neta Bendelac on preparing sites for Direct-to-Patient trials.

In this interview, 4G's newly appointed vice president of delivery Barry Moore discusses trial disruptions caused by the COVID-19 pandemic.

In this interview, van de Walle discusses the impact COVID-19 has had on her site, clinical research as a whole and the need for virtual trials. 

4G Clinical is a proud sponsor of the 2018 US GCSG Conference in Atlanta and the resulting white paper on BREXIT considerations for clinical supply professionals.

4G Clinical was featured in an eClinical solutions white paper as an innovative company enhancing randomization and trial supply management (agile RTSM).

4G Clinical named to top 20 most promising pharma & life sciences tech solution providers of 2017 for its use of NLP technology and agile software methodology.

4G's Christine Hurley speaks to the challenges of technology innovation and the strategies needed with randomization and trial supply management.

4G's Kathleen Greenough interviews Roger DeRaad about IRT usage at the site level.